Uses
FLUORESCITE ® Injection 10% is indicated in diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature.
Source: US FDA prescribing information
- Presentations
- 5
- Brands
- 2
- Manufacturers
- 2
- Available from stock
- 0
Fluorescein is a diagnostic dye indicated in diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature. It is available as injection for intravenous and ophthalmic use. MedsAcross supplies Fluorescein for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Diagnostic Dye, Dyes
- ATC classification
- S01JA01 Fluorescein · Eye medicines, subgroup S01J, subgroup S01JA
- US FDA first approval
- 10 November 1976
- EU status
- Not recorded
- Orphan designation
- Not recorded
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Intravenous, Ophthalmic
- Dosage forms
- Injection
- Identifiers
- UNII TPY09G7XIRRxCUI 25138CAS 2321-07-5DrugBank DB00693Q410922
Clinical information
From the regulator-approved product information. Each section names its source.
How it works
Fluorescein responds to electromagnetic radiation and light between the wavelengths of 465-490 nm and fluoresces, i.e., emits light at wavelengths of 520-530 nm. Thus, the hydrocarbon is excited by blue light and emits light that appears yellowish-green. Following intravenous injection of fluorescein in an aqueous solution, the unbound fraction of the fluorescein can be excited with a blue light flash from a fundus camera as it circulates through the ocular vasculature, and the yellowish green fluorescence of the dye is captured by the camera. In the fundus, the fluorescence of the dye demarcates the retinal and/or choroidal vasculature under observation, distinguishing it from adjacent areas/structures.
Source: US FDA prescribing information
Dosing overview
Adult Dose: The normal adult dose of FLUORESCITE® Injection 10% (100 mg/mL) is 500 mg via intravenous administration. Pediatric Dose: For children, the dose should be calculated on the basis of 7.7 mg for each kg of actual body weight (or 35 mg for each 10 pounds of body weight) up to a maximum of 500 mg via intravenous administration. Do not mix or dilute with other solutions or drugs
Source: US FDA prescribing information
Contraindications
FLUORESCITE ® Injection 10% is contraindicated in patients with known hypersensitivity to fluorescein or any other ingredients in this product Hypersensitivity FLUORESCITE ® Injection 10% is contraindicated in patients with known hypersensitivity to fluorescein or any other ingredients in this product. Rare cases of death due to anaphylaxis have been reported. Fluorescein can induce serious intolerance reactions.
Source: US FDA prescribing information
Warnings and precautions
Respiratory reactions may require intervention. Severe local tissue damage can occur with extravasation during injection. Nausea and/or vomiting may occur within minutes following injection.
Source: US FDA prescribing information
Side effects
The following adverse reactions associated with the use of FLUORESCITE were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The most common adverse reactions include skin discoloration, urine discoloration, nausea, vomiting, and gastrointestinal distress.
Source: US FDA prescribing information
Storage
Storage Store at 2°to 25°C (36° to 77°F). Do Not Freeze
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
All presentations
5 presentations of Fluorescein, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Fluorescein 500 mg/5 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Fluorescein 500 mg/2 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Ak-fluor 500 mg/5 mL injectionIntravenous | Long Grove Pharmaceuticals | US FDA | Available on request |
| Fluorescein 2500 mg/5 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Fluorescite 500 mg/5 mL injectionOphthalmic | Alcon | US FDA | Available on request |
Brands by market
2 brand names across 1 markets.
United States
Manufacturers
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 10 November 1976 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Questions and answers
Is Fluorescein available for export from India?
Yes, on request. MedsAcross lists 5 presentations of Fluorescein and sources them for licensed hospitals, importers and physicians against valid import documents.
What brand names does Fluorescein have?
The catalogue lists 2 brand names for Fluorescein, including Ak-fluor, Fluorescite.
Is Fluorescein approved by the US FDA?
Yes. The US FDA first approved Fluorescein on 10 November 1976, according to Drugs@FDA.
Does Fluorescein need cold chain shipping?
No listed presentation of Fluorescein is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Fluorescein in?
Fluorescein is classified under ATC code S01JA01 (Fluorescein).
References
- FLUORESCITE prescribing information (Alcon). U.S. National Library of Medicine, DailyMed. Retrieved 6 October 2026
Request Fluorescein for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.